SEC Form 4 · accession 0001437749-18-007095
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rice
Officer — President & CEO · Director
Period of report
Apr 16, 2018
Accepted (ET)
Apr 18, 2018 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 16, 2018 | M | 6,640 | $1.12 | A | 146,157 | D | |
| Common StockF2 | Apr 16, 2018 | S | 6,640 | $7.15 | D | 139,517 | D | |
| Common Stock | Apr 17, 2018 | M | 5,900 | $1.12 | A | 145,417 | D | |
| Common StockF3 | Apr 17, 2018 | S | 5,900 | $7.22 | D | 139,517 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option | $1.12 | Apr 16, 2018 | M | 6,640 | D | Aug 14, 2012 | Feb 24, 2021 | Common Stock | 6,640 | 116,307 | D |
| Employee Stock Option | $1.12 | Apr 17, 2018 | M | 5,900 | D | Aug 14, 2012 | Feb 24, 2021 | Common Stock | 5,900 | 110,407 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. (the "Registrant") on December 14, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.30, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.02 to $7.34, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.